CDC Chronic Disease Group Launches SDOH Workgroup

April 21, 2022
CDC’s National Center for Chronic Disease Prevention and Health Promotion says the project will follow the framework of the Gravity Project, an HL7 FHIR accelerator

The Centers for Disease Control and Prevention is establishing a cross-sector Social Determinants of Health (SDOH) Public Health Use Case Workgroup to engage public- and private-sector partners to advance SDOH data exchange for chronic disease prevention and health promotion.

The CDC’s National Center for Chronic Disease Prevention and Health Promotion’s Office of Informatics and Information Resources Management said the project will follow the framework of the Gravity Project, an HL7 FHIR accelerator.

The Gravity Project has made strides in establishing a foundation for representation and exchange of SDOH data across and between health- and community-based systems. One of the goals is to design and publish up to three high-priority public health-focused use cases that extend on those developed for care by the Gravity Project. 

The CDC noted that the integration of healthcare, public health, and social services can provide significant gains in combating upstream social risk factors, such as laws and policies that shape community conditions that are largely outside of the control of the individual.

Karen Hacker, M.D., M.P.H., director of CDC's National Center for Chronic Disease Prevention and Health Promotion, led off the introductory meeting of the workgroup on April 20. “As we see screening going on for social needs within the healthcare system, with the data being collected in electronic health records, we felt that it was important to be at the table, and to be developing the public health use cases about how this information on social determinants of health on social needs could be interpreted by public health and used by public health for decision-making,” she said.

Timothy Carney, Ph.D., M.P.H., director of the CDC’s Office of Informatics and Information Resource Management, added that as CDC officials conducted strategic planning activities to identify areas it needs to focus on in this space around social determinants, they realized they couldn’t make progress unless there's an underlying data strategy to support that scientific and programmatic work at the top.

“We needed to begin to think about how we're going to arrive at a common understanding of what critical data elements were essential in helping to drive social determinants of health activity, specifically through the lens of the public health and population health perspective,” Carney said. “We recognize that there are a lot of organizations, entities, activities, and individuals who are doing front-line work on social determinants and health equity. The goal of this work that we're doing, in partnership with EMI Advisors, is to help us identify opportunities to leverage this work as harmonization, or coalescing agents. Finally, we recognize also that many of us are building systems, solutions, technology applications, strategy, policies, etc. The hope however, is that we can identify a common framework, a future state diagram that all of us can begin to point to and identify as some North Star-like point, if you will, in the future that we want to build toward.”

.

Sponsored Recommendations

Care Access Made Easy: A Guide to Digital Self Service

Embracing digital transformation in healthcare is crucial, and there is no one-size-fits-all strategy. Consider adopting a crawl, walk, run approach to digital projects, enabling...

Powering a Digital Front Door with a Comprehensive Provider Directory

Learn how Geisinger improved provider data accuracy, SEO, and patient acquisition with a comprehensive provider directory.

Data-driven, physician-focused approach to CDI improvement

Organizational profile Sisters of Charity of Leavenworth (SCL) Health* has been providing care since it originated in the 1600s in France as the Daughters of Charity. These religious...

Luminis Health improved quality and financial outcomes with advanced CDI technology and consulting from 3M

In the beginning, there were challengesBefore partnering with 3M Health Information Systems (HIS), Luminis Health’s clinical documentation integrity (CDI) program faced ...

According to an Oct. 10 press release, a report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR). While some of these vaccines are already available but underused, others would need to be developed and brought to the market as soon as possible. AMR occurs when bacteria, viruses, fungi, and parasites no longer respond to antimicrobial medicines, making people sicker and increasing the risk of illness, death and the spread of infections that are difficult to treat. AMR is driven largely by the misuse and overuse of antimicrobials, yet, at the same time, many people around the world do not have access to essential antimicrobials. Each year, nearly 5 million deaths are associated with AMR globally. Vaccines are an essential part of the response to reduce AMR as they prevent infections, reduce the use and overuse of antimicrobials, and slow the emergence and spread of drug-resistant pathogens. The new report expands on a WHO study published in BMJ Global Health last year. It estimates that vaccines already in use against pneumococcus pneumonia, Haemophilus influenzae type B (Hib, a bacteria causing pneumonia and meningitis) and typhoid could avert up to 106 000 of the deaths associated with AMR each year. An additional 543 000 deaths associated with AMR could be averted annually when new vaccines for tuberculosis (TB) and Klebsiella pneumoniae, are developed and rolled out globally. While new TB vaccines are in clinical trials, one against Klebsiella pneumoniae is in early stage of development.
dreamstime_xxl_210174616_1